News Archive
2006 Archive | 2005 Archive | 2004 Archive | 2003 Archive | 2002 Archive
August 15, 2004
CellzDirect Presents New Research at ISSX 2004
February 11, 2004
CellzDirect Acquires HepatoTech's Cell Culture Business
CellzDirect Presents New Research at ISSX 2004
August 15th, 2004
CellzDirect, Inc. announced today its plan to present new research from some of the company's top scientists at the International Society for the Study of Xenobiotics (ISSX) Annual Conference on August 29, 2004 in Vancouver, Canada and the Hepatocyte Research Association (HRA) a satellite meeting of ISSX. CellzDirect’s Booth will be located in section 224. Dr. Chris Black, Dr. Geraldine Hamilton, Dr. Ed LeCluyse, David James Coon and Karen Wright, all senior scientists at CellzDirect will be presenting posters on “Comparison of in situ Vs. Microsomal Evaluation of CYP Evaluation of CYP Induction in Rat and Human Hepatocytes: Determination of Apparent CYP Kinetics” and “Effect of Rho Family Small GTPases on the Cell Adehesion-dependent expression of CYP3A4 in Primary Human Hepatocytes.” Dr. LeCluyse will be chairing the HRA meeting. Chief Scientific Officer, Dr. Ed LeCluyse stated “We look forward to the opportunity to present our research at this year's meeting. This year's conference looks to be a very strong scientific conference and we are excited about attending."
State-of-the-art Lab in North Carolina Complements Recent Acquisition of CEDRA's In Vitro Drug Metabolism Unit
Press Release, February 11, 2004
CellzDirect Inc., a cell-based biotech company, announced today that it has acquired the assets and expertise of HepatoTech Inc., including its new cell-culture facilities located outside Research Triangle Park in North Carolina. HepatoTech's scientific focus has been to optimize the isolation and culture of high-quality hepatocytes from multiple species. Hepatocytes have become the "gold standard" in the pharmaceutical industry for evaluating liver metabolism and toxicity of new drug candidates and other chemical entities. learn more >>
